News and Comments

Huge Improvement in the Differential Diagnosis of Diseases and More

  Wednesday, September 02, 2015

Biotechnology industry is proving to be the most innovative and the most growing among WallStreet industries. Individual biotech companies’ achievements complement each other. Some are evolving the sequencing of genes and genetic analysis, while others are excelling in designing drugs based on the tremendous amount of facts they are getting on root causes of the diseases and the interaction of proteins. The biotech companies have largely improved their drug discovery, design and development, including clinical trial plans and strategies.   More...

Why Switzerland Approval of Exelixis and Roche Drug Combination for melanoma is a Big Deal?

  Thursday, August 27, 2015


Seres Therapeutics: A novel Approach For Treating Clostridium Difficile infection.

  Friday, August 21, 2015

but First: Here is some Good News From  More...

KITE: News we are Anxious to Hear

  Monday, August 17, 2015

Kite Pharma (Kite) stock was sliding, raising concern about the firm and all the biotech firms that are designing and developing CAR T Cell immunotherapy treatments for cancer. Many investors are wondering about the plummeting of the stock and obviously others have learned about one death that occurred during clinical trial, which caused KITE selloff.    More...

Inovio is in Much Better Shape than Six Months Ago

  Thursday, August 13, 2015

INOVIO More...

AstraZeneca Selects Mirati Therapeutics Drug For Its cancer Immunotherapy Combination

  Thursday, August 06, 2015

In The NEWS More...

NANTKWEST INC. A Novel Breathtaking Immunotherapy For Cancer?

  Monday, August 03, 2015

The moment the new IPO NantKwest (NK) landed in the town of publicly traded firms, some called it the “New Golden Boy”. During the IPO, investors who knew about this firm and were waiting for that day seemed confident that the stock would surge. As a matter of fact, the stock did surge.    More...

EXELEXIS: The Importance Of The Public Offering. XOMA: What Should We Do Now?

  Thursday, July 23, 2015

Why the financing through a secondary public offering was a must for Exelixis?  More...

AMGN: Rapatha Approved In Europe

  Tuesday, July 21, 2015

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol More...

Anacor Pharmaceuticals Ointment for Atopic Dermatitis Passes the Tests. Why is this Great News?

  Tuesday, July 14, 2015

An Effective Non-Steroid Atopic Dermatitis Ointment More...

Recent Postings



Idenix (IDIX) Pluristem (PSTI) ABBVIE (ABBV) Editas (EDIT) Theravance (THRX) galapagos (GLPG) ARCA (ABIO) Ziofpharm (ZIOP) INNOVIVA (INVA) ACADIA (ACAD) Velcade (bortezomib) Advaxis (ADXS) Revlimid (lenolidamide) Spike Therapeutics (ONCE) Bellicum (BLCM) ARGOS (ARGS) Aimmune Therapeutics (AIMT) NANTKWEST (NK) RenenxBio (RGNX) Anacor (ANAC) ISIS (ISIS) MODERNA Micromet (MITI) Alnylam (ALNY) Onyx (ONXX) Human Longevity (HLI) Regeneron (REGN) Sanofi (SNA) Exelixis (EXEL) Agenus (AGEN) Tysabri NOVOCURE (NVCR) SUNESIS PHARMACEUTICALS (SNSS) Bristol-Myers Squibb (BMY) Theravance Bio Pharma (TBPH) KERYX (KERX) Incyte (INCY) Inovio (INO) Agenus (AGEN Abbott Laboratories (ABT) Human Genome Sciences (HGSI) GlaxoSmithKline (GSK) Alder Biopharmaceuticals (ALDR) KITE (KITE) Array Pharmaceuticals (ARRY) JUNO (JUNO) Mirati Therapeutics (MRTX) Anadys (ANDS) Roche (RHHBY) OSI (OSIP) IDERA (IDRA) Genentech Elan (ELN) Benlysta (belimumab) Prolor Biotech (PBTH) AGOS (ARGS) Sanofi-Aventis (SAN) Sanofi (SNY) Endometrial Cancer Illumina (ILMN) Sequenom (SQNM) Jazz Pharmaceuticals (JAZZ) Global Cell Therapeutics (GBT) CompuGen (CGEN) Rapamune SYNTA (SNTA) Prosensa (RNA) AstraZeneca (AZN) Sarepta (SRPT) Vitae Pharmaceuticals (VTAE) NEKTAR (NKTR)) Intermune (ITMN) Auspex (ASPX) C4 Therapeutics Trastuzumab-DM1 Roche (ROCHE) Sangamo (SGMO) Ionis (IONS) Seattle Genetics (SGEN) Intrexon (XON) Xoma (XOMA) ADVENTRIX (ANX) Dendreon (DNDN) SERES THERAPEUTICS (MCRB) Biocryst (BCRX) Cytokinetics (CYTK) PTC Therapeutics (PTCT) REGULUS (RGLS) Galena (GALE) Ridaforolimus Telaprevir Valeant Pharmaceuticals International (VRX) GUARDIAN HEALTH Biogen Idec (BIIB) Vertex (VRTX) VANDA (VNDA) Adaptimmune (ADAP) TOKAI (TKAOI) ImmunoGen (IMGN) Dynavax (DVAX) Multiple Myeloma Merck (MRK) BIOMARIN (BMRN) Gilead (GILD) HALOZYME (HALO) ZALTRAP™ Zerenex Herceptin AERIE PHARMACEUTICALS Intercept (ICPT) Ariad (ARIA) Amgen (AMGN)